County Public Schools has joined dozens of other school systems and institutions in suing pharmaceutical and pharmacy companies, alleging that the companies manipulated the prices of insulin and other ...
Earlier this month, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulinproducts in the US – Sanofi's Lantus, Novo Nordisk's Novolog and Eli Lilly's Humalog ...
Products under the program include insulin vials, pens, continuous glucose monitors and pumps by manufacturers Novo Nordisk, Eli Lilly, Sanofi, Dexcom and Insulet. About one in 10 Americans have ...
Last year, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulinproducts in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's Humalog – by 2024.